Does OCRELIZUMAB Cause Neuropathy peripheral? 141 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 141 reports of Neuropathy peripheral have been filed in association with OCRELIZUMAB (OCREVUS). This represents 0.3% of all adverse event reports for OCRELIZUMAB.
141
Reports of Neuropathy peripheral with OCRELIZUMAB
0.3%
of all OCRELIZUMAB reports
0
Deaths
49
Hospitalizations
How Dangerous Is Neuropathy peripheral From OCRELIZUMAB?
Of the 141 reports, 49 (34.8%) required hospitalization, and 2 (1.4%) were considered life-threatening.
Is Neuropathy peripheral Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OCRELIZUMAB. However, 141 reports have been filed with the FAERS database.
What Other Side Effects Does OCRELIZUMAB Cause?
Covid-19 (11,454)
Fatigue (5,704)
Urinary tract infection (3,618)
Headache (3,036)
Multiple sclerosis (2,609)
Asthenia (2,509)
Nasopharyngitis (2,479)
Gait disturbance (2,384)
Pneumonia (2,333)
Pain (2,327)
What Other Drugs Cause Neuropathy peripheral?
LENALIDOMIDE (10,215)
BORTEZOMIB (4,067)
OXALIPLATIN (3,662)
DEXAMETHASONE (3,543)
PACLITAXEL (3,508)
LEVOFLOXACIN (2,619)
CIPROFLOXACIN (2,607)
FLUOROURACIL (2,605)
CYCLOPHOSPHAMIDE (2,565)
POMALIDOMIDE (2,382)
Which OCRELIZUMAB Alternatives Have Lower Neuropathy peripheral Risk?
OCRELIZUMAB vs OCRIPLASMIN
OCRELIZUMAB vs OCTINOXATE\OCTISALATE\ZINC
OCRELIZUMAB vs OCTINOXATE\OCTOCRYLENE
OCRELIZUMAB vs OCTREOTIDE
OCRELIZUMAB vs OCTREOTIDE\OCTREOTIDE